SEC Form 4 · accession 0001209191-18-053539
Entasis Therapeutics Holdings Inc. · ETTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
Michael Powell
10% Owner
James Healy
10% Owner
Anand Mehra
10% Owner
Sofinnova Venture Partners IX, L.P.
10% Owner
Sofinnova Management IX, L.L.C.
10% Owner
Period of report
Sep 28, 2018
Accepted (ET)
Oct 2, 2018 · 9:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001724344
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Sep 28, 2018 | C | 359,267 | — | A | 359,267 | D | |
| Common StockF1,F3,F2 | Sep 28, 2018 | C | 458,425 | — | A | 842,454 | D | |
| Common StockF2 | Sep 28, 2018 | P | 337,724 | $15.00 | A | 1,180,178 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series B-1 Tranche A Convertible Preferred StockF2,F1 | — | Sep 28, 2018 | C | 7,446,904 | D | — | — | Common Stock | 359,267 | 0 | D |
| Series B-1 Tranche B Convertible Preferred StockF2,F1 | — | Sep 28, 2018 | C | 9,502,249 | D | — | — | Common Stock | 458,425 | 0 | D |
Explanation of responses
- F1Each share of Series B-1 Tranche A Convertible Preferred Stock and Series B-1 Tranche B Convertible Preferred Stock (collectively, the "Preferred Stock") automatically converted into Common Stock on a 20.728-for-one basis upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date.
- F2The reportable shares are held of record by Sofinnova Venture Partners IX, L.P. ("SVP IX"). Sofinnova Management IX, L.L.C. ("SM IX") is the general partner of SVP IX. The individual managing members of SM IX are Michael Powell, James Healy and Anand Mehra, and they may be deemed to share voting and dispositive power over the shares held by SVP IX. Such persons and entities disclaim beneficial ownership over the shares held by SVP IX except to the extent of any pecuniary interest therein.
- F3This number includes an aggregate of 24,762 shares of Common Stock received upon the conversion of the Issuer's Preferred Stock as payment of the accrued dividends through September 27, 2018. No dividends will accrue after September 27, 2018.